Showing results (61-70 of 106) with videos related to

Sort By:
Pageof 11
Applied Physiology, Nutrition, and Metabolism = Physiologie Appliquee, Nutrition Et Metabolisme|December 7, 2018
Hemodynamic responses to an exercise stress test in Parkinson's disease patients without orthostatic hypotensionKirk B Roberson, Joseph F Signorile, Carlos Singer, et al.
CNS Drugs|March 14, 2018
Pooled Analyses of Phase III Studies of ADS-5102 (Amantadine) Extended-Release Capsules for Dyskinesia in Parkinson's DiseaseLawrence W Elmer, Jorge L Juncos, Carlos Singer, et al.
CNS Drugs|April 12, 2018
Author Correction to: Pooled Analyses of Phase III Studies of ADS-5102 (Amantadine) Extended-Release Capsules for Dyskinesia in Parkinson's DiseaseLawrence W Elmer, Jorge L Juncos, Carlos Singer, et al.
Neurology. Clinical Practice|June 5, 2023
Ulotaront, a Trace Amine-Associated Receptor 1/Serotonin 5-HTStuart H Isaacson, Mark Goldstein, Rajesh Pahwa, et al.
Clinical Neuropharmacology|August 2, 2008
Caffeine and progression of Parkinson diseaseDavid K Simon, Christopher J Swearingen, Robert A Hauser, et al.
Parkinsonism & Related Disorders|March 28, 2015
Randomized, controlled pilot trial of solifenacin succinate for overactive bladder in Parkinson's diseaseTheresa A Zesiewicz, Marian Evatt, Camille P Vaughan, et al.
Neurology. Clinical Practice|December 29, 2023
Blepharoclonus in ParkinsonismJason Margolesky, Matthew Feldman, Sarah Marmol, et al.
Parkinsonism & Related Disorders|February 26, 2019
Revisiting eligibility for deep brain stimulation: Do preoperative mood symptoms predict outcomes in Parkinson's disease patients?Marina Sarno, Wendy Gaztanaga, Nikhil Banerjee, et al.
Journal of Parkinson'S Disease|September 7, 2020
Minority Enrollment in Parkinson's Disease Clinical Trials: Meta-Analysis and Systematic Review of Studies Evaluating Treatment of Neuropsychiatric SymptomsDaniel G Di Luca, Jacob A Sambursky, Jason Margolesky, et al.
Journal of Parkinson'S Disease|October 8, 2015
Conversion to IPX066 from Standard Levodopa Formulations in Advanced Parkinson's Disease: Experience in Clinical TrialsPaul A Nausieda, Ann Hsu, Lawrence Elmer, et al.
Pageof 11